Literature DB >> 19131894

Carotid intima-media thickness and arterial stiffness in HIV-infected patients: the role of HIV, antiretroviral therapy, and lipodystrophy.

Marit G A van Vonderen1, Yvo M Smulders, Coen D A Stehouwer, Sven A Danner, Chad M Gundy, Frieda Vos, Peter Reiss, Michiel A van Agtmael.   

Abstract

OBJECTIVES: HIV-infected patients using combination antiretroviral therapy (ART) have an increased cardiovascular risk. We aimed to identify the effects of HIV, ART, and lipodystrophy (LD) on carotid artery intima-media thickness (C-IMT), a surrogate measure of atherosclerosis, and arterial stiffness, a marker of cardiovascular risk.
DESIGN: Case-control study of 77 HIV-infected men (55 exposed to ART, 22 ART naive, and 23 with LD) and 52 controls.
METHODS: C-IMT was measured ultrasonically, and arterial stiffness was estimated by distensibility (DC) and compliance (CC) coefficients of the carotid, femoral, and brachial arteries, by the carotid Young elastic modulus and pulse wave velocity.
RESULTS: After adjustment for cardiovascular risk factors, HIV-infected patients had a 0.067 mm (10.8%) greater C-IMT than controls, 13.6% and 29.5% lower DC, and 14.1% and 31% lower CC of the carotid and femoral arteries, respectively, but similar Young elastic modulus and pulse wave velocity. Patients exposed to ART had similar C-IMT compared with ART-naive patients but 25.9% lower DC and 21.7% lower CC of the femoral artery. Arterial properties did not differ between patients with and without LD.
CONCLUSIONS: HIV infection is independently associated with C-IMT and generally increased arterial stiffness. ART use is associated with increased stiffness of the femoral artery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19131894     DOI: 10.1097/QAI.0b013e31819367cd

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  33 in total

1.  Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection.

Authors:  Emily S Ford; Jamieson H Greenwald; Aaron G Richterman; Adam Rupert; Lauren Dutcher; Yunden Badralmaa; Ven Natarajan; Catherine Rehm; Colleen Hadigan; Irini Sereti
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

Review 2.  Biomarkers and HIV-associated cardiovascular disease.

Authors:  Jason V Baker; Daniel Duprez
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

Review 3.  Cardiovascular implications from untreated human immunodeficiency virus infection.

Authors:  Jason V Baker; Jens D Lundgren
Journal:  Eur Heart J       Date:  2011-01-12       Impact factor: 29.983

4.  Early vascular aging in the HIV infected: Is arterial stiffness assessment the ideal tool?

Authors:  Carla M T Fourie; Aletta E Schutte
Journal:  Virulence       Date:  2017-05-03       Impact factor: 5.882

5.  Azidothymidine (AZT) leads to arterial stiffening and intima-media thickening in mice.

Authors:  Laura Hansen; Ivana Parker; LaDeidra Monet Roberts; Roy L Sutliff; Manu O Platt; Rudolph L Gleason
Journal:  J Biomech       Date:  2013-04-25       Impact factor: 2.712

6.  A prospective cohort study of periodontal disease measures and cardiovascular disease markers in HIV-infected adults.

Authors:  Lance T Vernon; Denise C Babineau; Catherine A Demko; Michael M Lederman; Xuelei Wang; Zahra Toossi; Aaron Weinberg; Benigno Rodriguez
Journal:  AIDS Res Hum Retroviruses       Date:  2011-05-09       Impact factor: 2.205

7.  Brachial and central blood pressure in HIV-infected subjects.

Authors:  Alessandro Maloberti; Dario Dozio; Mauro Betelli; Alessandra Bandera; Nicola Squillace; Andrea Gori; Giovanna Castoldi; Andrea Stella; Giuseppe Mancia; Cristina Giannattasio
Journal:  Hypertens Res       Date:  2015-03-05       Impact factor: 3.872

8.  Risk of cardiovascular disease in HIV, hepatitis C, or HIV/hepatitis C patients compared to the general population.

Authors:  L Kakinami; R C Block; M J Adams; S E Cohn; B Maliakkal; S G Fisher
Journal:  Int J Clin Pract       Date:  2013-01       Impact factor: 2.503

9.  Cardiovascular, renal and liver events associated with human immunodeficiency virus type 1 infection and antiretroviral therapy.

Authors:  Eric S Daar
Journal:  F1000 Med Rep       Date:  2009-05-28

10.  Elevated Markers of Vascular Remodeling and Arterial Stiffness Are Associated With Neurocognitive Function in Older HIV+ Adults on Suppressive Antiretroviral Therapy.

Authors:  Jessica L Montoya; Jennifer Iudicello; Pariya L Fazeli; Suzi Hong; Michael Potter; Ronald J Ellis; Igor Grant; Scott L Letendre; David J Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2017-02-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.